(Press-News.org) A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a severe form of spina bifida. This is the first time live stem cells have been used on a fetus’ damaged spine, which could potentially lead to better health outcomes for babies compared to traditional fetal surgery.
Spina bifida is a congenital condition in which the spinal cord does not develop properly, leaving part of it exposed. This can cause lifelong health challenges, including paralysis, difficulty walking, and issues with bladder and bowel control. Current treatments involve surgery during pregnancy to close the spinal opening, which can reduce some complications but often does not prevent all neurological problems.
In the trial, six pregnant women with fetuses diagnosed with spina bifida underwent standard fetal surgery plus an additional step where surgeons applied cells from the placenta—called placenta-derived mesenchymal stem cells (PMSCs)—directly onto the exposed spinal cord during the surgery. These cells are known for their ability to reduce inflammation, promote healing, and protect nerve tissue.
All six babies, who were born between July 2021 and December 2022, had their spinal repairs intact and showed no signs of infection, abnormal tissue growth, or tumour formation. Post-birth MRI scans confirmed that brain abnormalities associated with spina bifida, called hindbrain herniation, were reversed in every case.
In addition, the infants experienced no serious adverse effects attributable to the stem cell treatment during the trial and through follow-up care. The children in this trial will be carefully monitored, with regular check-ups and assessments, until they turn six. This long-term follow-up will help researchers confirm that the stem cell treatment remains safe and improves children’s mobility, health, and quality of life as they grow.
Additional large-scale, long-term clinical trials are underway to further refine surgical techniques and treatment protocols. These studies aim to confirm that children who receive this therapy experience benefits at birth, improved mobility, and a better quality of life. Throughout this process, regulatory agencies will work closely with the research team to carefully monitor safety and effectiveness.
The researchers aim to establish this stem cell therapy as a safe and standard option for fetal repair of spina bifida, providing new hope for families affected by this condition worldwide. They say these results represent a major milestone in the field of in-utero stem cell treatment for birth defects, paving the way for future advances using stem cells during fetal surgery to address other congenital conditions.
Post-embargo URL: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)02466-3/fulltext
END
The Lancet: First-ever in-utero stem cell therapy for fetal spina bifida repair is safe, study finds
2026-02-27
ELSE PRESS RELEASES FROM THIS DATE:
Nanoplastics can interact with Salmonella to affect food safety, study shows
2026-02-26
URBANA, Ill. – Plastic products are ubiquitous in our food supply chain, shedding microplastics into every part of the human ecosystem. As they degrade, microplastics break down into even smaller fragments called nanoplastics — tiny particles that can affect biological molecules in ways not fully understood. In a new study, researchers at the University of Illinois Urbana-Champaign examined what happens when nanoplastics interact with Salmonella, potentially affecting food safety and human health.
“Salmonella enterica is a major foodborne ...
Eric Moore, M.D., elected to Mayo Clinic Board of Trustees
2026-02-26
JACKSONVILLE, Florida — Eric Moore, M.D., medical director of Mayo Clinic International and chair of the Department of Otolaryngology in Rochester, was elected to the Mayo Clinic Board of Trustees at its quarterly meeting on Feb. 20.
"Dr. Moore is an internationally respected leader whose commitment to patients and strategic vision will be a tremendous asset to our Board of Trustees," says Gianrico Farrugia, M.D., president and CEO, Mayo Clinic. “His extensive experience and collaborative approach will help guide our strategic ...
NYU named “research powerhouse” in new analysis
2026-02-26
New York University is recognized as one of the 70 top research institutions consistently home to the world’s most-cited researchers over the past five years. The analysis of “research powerhouses,” led by the analytics company Clarivate, demonstrates where research impact is most concentrated.
Since 2001, Clarivate has identified “highly cited researchers”—a group of scientists and social scientists whose research published over the last decade has demonstrated ...
New polymer materials may offer breakthrough solution for hard-to-remove PFAS in water
2026-02-26
Scientists are developing a new generation of polymer-based materials that could dramatically improve the removal of persistent “forever chemicals” from drinking water, according to a new review synthesizing recent advances in environmental remediation research.
Per- and polyfluoroalkyl substances, known as PFAS, are a large class of human-made chemicals used in products ranging from firefighting foams to nonstick cookware and textiles. Their extreme stability allows them to persist in the environment and accumulate in water supplies, raising growing concerns about long-term ...
Biochar can either curb or boost greenhouse gas emissions depending on soil conditions, new study finds
2026-02-26
A new study reveals that biochar, a carbon rich material increasingly promoted for climate friendly agriculture, can have sharply different effects on greenhouse gas emissions depending on soil type and land use. The research shows that while biochar can significantly reduce nitrous oxide emissions in acidic upland soils, it may unexpectedly increase emissions in flooded rice paddies.
Nitrous oxide is one of the most potent greenhouse gases, with a warming effect far greater than carbon dioxide over the long term. Agricultural soils are a major source of these emissions, making mitigation strategies critical for climate and food system sustainability.
In the ...
Nanobiochar emerges as a next generation solution for cleaner water, healthier soils, and resilient ecosystems
2026-02-26
A new scientific review points to nanobiochar, an engineered carbon material derived from biomass, as a promising solution for some of the world’s most pressing environmental challenges. By shrinking conventional biochar to the nanoscale, researchers have created a material with dramatically increased surface area, reactivity, and environmental functionality, opening new possibilities for soil improvement, water treatment, and climate resilience.
Biochar has long been used to improve soil quality and capture carbon, but the new analysis shows that nanoscale versions ...
Study finds more parents saying ‘No’ to vitamin K, putting babies’ brains at risk
2026-02-26
EMBARGOED FOR RELEASE UNTIL 4:00 P.M. ET, THURSDAY, FEBRUARY 26, 2026
Highlights:
A new review of research has found the number of parents refusing vitamin K injections for their newborns is on the rise.
Vitamin K is an essential vitamin that is naturally low in newborns. Vitamin K at birth is needed to help blood to clot. It is not a vaccine.
Babies who do not receive vitamin K at birth are at a higher risk of life-threatening brain bleeds and long-term disability.
While vitamin K refusal remains low, less than 1%, the review found rates of refusal in Minnesota ...
Scientists develop new gut health measure that tracks disease
2026-02-26
Scientists have identified a new way to distinguish healthy guts from diseased ones and track how some illnesses progress by measuring how gut bacteria interact with one another.
According to a study published in Science, a collaboration between scientists at Rutgers University, Universidad de Granada in Spain and Princeton University found that healthy and diseased gut microbiomes behave like two distinct ecological states, driven not by individual microbes but by how entire bacterial communities compete and cooperate.
“Instead ...
Rice gene discovery could cut fertiliser use while protecting yields
2026-02-26
UNDER EMBARGO UNTIL 19:00 GMT / 14:00 ET THURSDAY 26 FEBRUARY 2026
Rice gene discovery could cut fertiliser use while protecting yields
Researchers from the University of Oxford, Nanjing Agricultural University, and Institute of Genetics and Developmental Biology (Chinese Academy of Sciences) have finally identified the master regulator in plants that balances root and shoot growth when nutrients are limited. In field trials, rice plants with an improved version of the gene had yield increases of up to 24%. The breakthrough, published today (26 February) in the prestigious ...
Jumping ‘DNA parasites’ linked to early stages of tumour formation
2026-02-26
A study published today in the journal Science reveals how jumping fragments of human DNA, a type of genetic parasite, destabilise the cancer genome. Unstable genomes are a fertile playground for cancer evolution, giving malignant cells more opportunities to grow, adapt and evade treatment.
The researchers analysed genome sequences from tumours with unusually high activity of LINE-1 (L1) elements, fragments of DNA which copy themselves and paste that copy into other locations within the genome.
Previously thought ...